Evonik stock: Berenberg raises target for Evonik stock to EUR 20.00

Published on 10/20/2026 at 15:33 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Evonik's next results are due November 3, 2026. Evonik stock costs EUR 21.05 on October 20, 2026, down 1.36 percent versus the Xetra close.

Analyst target and reporting date

Berenberg raised its Evonik target from EUR 15.50 to EUR 20.00 on October 5, 2026.
Adjusted EBITDA rose 24.00 percent to EUR 630.00 million in the second quarter of 2026.
Evonik stock costs EUR 21.05 at Lang & Schwarz on October 20, 2026 at 3:30 p.m. CEST, 1.36 percent below the Xetra close of October 19, 2026, and 3.62 percent below its 52-week high.
Evonik is scheduled to report third-quarter 2026 results on November 3, 2026.

Aquarellmalerei der Essener Skyline mit Villa Hügel und Industriesilhouetten am Baldeneysee — Evonik Industries DE000EVNK013 als Aquarellmalerei der Essener Stadtlandschaft mit Industriesilhouette am Baldeneysee, Illustration mit AI erstellt.

Evonik Industries (ISIN DE000EVNK013) is trading against a Berenberg price target of EUR 20.00, raised from EUR 15.50 on October 5, 2026, according to Yahoo Finance. The new target is 4.99 percent below the EUR 21.05 price. Evonik was trading at EUR 21.05 at Lang & Schwarz on October 20, 2026 at 3:30 p.m. CEST, down 1.36 percent versus the Xetra close of October 19, 2026 at EUR 21.34.

Berenberg target moves higher

Berenberg upgraded Evonik to Hold from Sell and lifted its target to EUR 20.00 from EUR 15.50 on October 5, 2026, Yahoo Finance reported. Analyst Sebastian Bray linked the revised view to BASF's takeover interest, while also pointing to earnings pressure in methionine and other portfolio areas. The target remains below the current market price, making the rating change more cautious than the numerical increase suggests.

Price stays below the yearly high

At EUR 21.05, Evonik stock was 3.62 percent below its 52-week high of EUR 21.84 and 68.53 percent above its 52-week low of EUR 12.49 on October 20, 2026. Trading volume stood at 220,761 shares, while market capitalization was EUR 9.8 billion. The price decline of 1.36 percent was smaller than the 2.00 percent threshold that would make the daily move the main market event.

Second-quarter rebound meets November date

Evonik's adjusted EBITDA rose 24.00 percent to EUR 630.00 million in the second quarter of 2026, while management raised its adjusted EBITDA guidance for 2026 to EUR 2.0 billion to EUR 2.2 billion from EUR 1.7 billion to EUR 2.0 billion, according to Lightyear. The guidance range reflects the company's adjusted measure and should not be read as a GAAP earnings forecast. Evonik's investor-relations calendar lists November 3, 2026 for its third-quarter 2026 reporting, according to Evonik.

Valuation keeps the market cautious

Evonik's price-to-earnings ratio was 81.36 and its trailing dividend yield was 0.05 percent on October 20, 2026. Those figures sit alongside the 2026 second-quarter rebound and the scheduled November reporting date, leaving the next results as the clearest test of whether the temporary earnings lift is broadening.

Evonik stock remains near its high

The stock was trading at EUR 21.05 at Lang & Schwarz on October 20, 2026 at 3:30 p.m. CEST, 1.36 percent below the Xetra close of October 19, 2026 at EUR 21.34.

The further course of trading is shown by the continuously updated real-time quote of Evonik stock.